中医药协同体外受精-胚胎移植技术治疗多囊卵巢综合征所致不孕症

In Vitro Fertilization-Embryo Transfer Technique Combined with TCM in Treatment of Polycystic Ovary Syndrome

中医药协同体外受精-胚胎移植技术治疗多囊卵巢综合征患者不孕症有着明显的优势,一方面,中医药立足于整体观念,可根据患者的临床表现明确病因、病机,保证疗效的可靠性及有效性;另一方面,中医药治疗能够依据疾病的发展阶段,结合人、时间、地点而采取不同的治疗方法,使每个患者都能接受最适合自己的治疗方案。另外,中药大多来自天然动植物,不良反应小,给患者带来的损害相对较小,与体外受精-胚胎移植技术联合运用,可显著提高多囊卵巢综合征患者的妊娠率。

In vitro fertilization-embryo transfer technique combined with Traditional Chinese medicine has an obvious advantage in treating for infertility of patients with polycystie ovary syndrome. On the one hand, traditional Chinese medicine is based on the whole concept of human body and the etiology and pathogenesis can be confirmed according to the patient＇s clinical manifesta- tions, hence the curative effect can be ensured. On the other hand, Chinese medicine treatment can be carried out based on the stage of disease development, by combining factors of people, time and place different treatment can be applied so that each patient can accept the most suitable treatment. In addition, most of traditional Chinese medicines are natural plants and animals. With fewer adverse reactions and less damage to patients, it can be applied with in vitro fertilization-embryo transfer technique and significantly improve the pregnancy rate of patients with polycystic ovary syndrome.